$10.00
-0.66-6.19%
Pre-Market: Nov 19, 6:55 PM EDT
Comments
Loading...
Benitec Biopharma (NASDAQ:BNTC) Stock, Earnings Estimates, EPS, And Revenue
Benitec Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 3
EPS Estimate
$-0.430
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Benitec Biopharma using advanced sorting and filters.
Data brought to you by Benzinga APIs
Benitec Biopharma (BNTC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-0.48 | $-0.43 | -11.6 % |
| Mar 2024 | 2024-05-13 | $-1.64 | $-0.78 | -110.3 % |
| Mar 2023 | 2023-05-15 | $-2.72 | $-3.40 | 2000.0 % |
| Dec 2022 | 2023-02-13 | $-3.40 | $-1.87 | -8181.8 % |
Benitec Biopharma (BNTC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Benitec Biopharma (NASDAQ:BNTC) reporting earnings?
Benitec Biopharma (BNTC) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on November 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Benitec Biopharma (NASDAQ:BNTC)?
The Actual EPS was $-0.48, which missed the estimate of $-0.43.
What were Benitec Biopharma’s (NASDAQ:BNTC) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.